Imaging study for liver metastasis surgery
Part of Cancer, Digestive system, Skin clinical trials.
This study looks at how well imaging predicts the outcome of surgery for liver metastases from colorectal or breast cancer. If you are having surgery to remove liver metastases, you may be able to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have colorectal or breast cancer that has spread to the liver, and you must be scheduled for surgery to remove the liver metastases.
- You must have had an MRI or CT scan of the liver within 12 weeks before surgery (ideally within 4 weeks).
- You cannot have had radiofrequency ablation or chemoembolization as a prior treatment for the liver metastases that will be operated on.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well MRI can evaluate liver metastases (spread to the liver) from colorectal cancer. If you have measurable liver lesions, your MRI results may help doctors better track and plan care.
This study looks at MRI scans and tissue samples from people with colorectal cancer that has spread to the liver. The goal is to find patterns that might predict whether the cancer will come back after surgery, which could help guide future treatment.
This trial compares two types of MRI scans to see if one is as good as the other for finding and tracking liver tumors in people with colorectal cancer. You can join if you are starting chemotherapy or need your cancer checked.
This trial tests whether special liver imaging can help doctors choose or guide the best chemotherapy for people with liver metastases from gastrointestinal cancer. The study focuses on comparing imaging-based information with outcomes during common chemo treatments like CAPOX or FOLFOX.
This study uses a special MRI to look at liver metastases from colorectal cancer, aiming to see how well the MRI can see the tumors and how they respond to chemotherapy. If you qualify, you'll have an extra MRI before starting chemotherapy, which might help doctors understand the cancer better.
This study uses your liver MRI scans and medical information to build a tool that predicts survival after surgery for colorectal cancer that has spread to the liver. It may help doctors better understand your outlook and plan care.
Hear when a new Liver Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.